Author:
Lu Dan,Lu Tong,Stroh Mark,Graham Richard A.,Agarwal Priya,Musib Luna,Li Chi-Chung,Lum Bert L.,Joshi Amita
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference61 articles.
1. Sacks LV, Shamsuddin HH, Yasinskaya YI, Bouri K, Lanthier ML, Sherman RE (2014) Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000–2012. JAMA 311(4):378–384. doi: 10.1001/jama.2013.282542
2. Mathijssen RH, Sparreboom A, Verweij J (2014) Determining the optimal dose in the development of anticancer agents. Nat Rev Clin Oncol 11(5):272–281. doi: 10.1038/nrclinonc.2014.40
3. Minasian L, Rosen O, Auclair D, Rahman A, Pazdur R, Schilsky RL (2014) Optimizing dosing of oncology drugs. Clin Pharmacol Ther. doi: 10.1038/clpt.2014.153
4. Schilsky RL (2015) Moving from evaluation to value in cancer care. Clin Cancer Res 21(5):947–949. doi: 10.1158/1078-0432.CCR-14-2533
5. Goldie JH, Coldman AJ (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63(11–12):1727–1733
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献